Shingles Vaccine UK 2026: Cost, NHS Eligibility, Shingrix Private Price, and Where to Get It
The shingles vaccine programme in the UK has undergone significant changes since 2023 — a new vaccine (Shingrix), expanded age eligibility, and from September 2025, protection extended to all severely immunosuppressed adults aged 18 and over. If you are in your 50s or early 60s and wondering why you have not been invited, it is because the NHS rollout is phased and you may be years away from eligibility — but you do not have to wait. Here is the complete 2026 guide to NHS eligibility, what Shingrix costs privately, where to get it, and what to expect.
This article is for educational and informational purposes only. Consult your GP or pharmacist for advice specific to your health situation.
What Is Shingles?
Shingles is a painful condition caused by the reactivation of the Varicella-Zoster virus — the same virus that causes chickenpox. After a childhood chickenpox infection, the virus does not leave the body; it retreats to nerve tissue and lies dormant. As we age, the immune system gradually loses its ability to keep the virus suppressed, and in some people it reactivates as shingles, causing:
- A painful, often burning or tingling sensation in one area of the body
- A distinctive rash of blisters, usually appearing as a band or strip on one side of the torso, face, or limb
- Fever, headache, and fatigue
Approximately 1 in 4 people will get shingles at some point in their lifetime. The condition itself is miserable enough — but the most feared consequence is post-herpetic neuralgia (PHN), a chronic nerve pain that persists long after the rash clears. PHN can last months or years and can be severely debilitating, particularly in older adults.
Before the introduction of the NHS shingles vaccination programme in 2013, shingles caused an estimated 4,500 hospital admissions per year in England. Within the first three years of vaccination, NHS England reported 17,000 fewer shingles episodes and 3,300 fewer PHN episodes among the eligible population.
The Shingrix Vaccine: What It Is and Why It Replaced Zostavax
The current NHS shingles vaccine is Shingrix, manufactured by GSK. The previous vaccine, Zostavax, was a live attenuated vaccine given as a single dose. Shingrix is a fundamentally different type of vaccine:
| Shingrix (current) | Zostavax (previous) | |
| Type | Non-live, adjuvanted recombinant subunit vaccine | Live attenuated vaccine |
| Doses | 2 doses (6-12 months apart) | Single dose |
| Suitable for immunocompromised? | Yes — non-live | No — live vaccine |
| Effectiveness | Over 90% against shingles; ~85% against PHN | About 51% against shingles (at time of introduction) |
| Side effects | More pronounced (due to AS01B adjuvant) | Generally milder |
The switch from Zostavax to Shingrix means significantly better protection and, crucially, eligibility for immunocompromised patients who could not safely receive the live Zostavax vaccine. If you previously received one or two doses of Zostavax and have since become immunosuppressed, NHS guidance recommends you now receive 2 doses of Shingrix.
NHS Shingles Vaccine Eligibility 2026
The NHS shingles vaccination programme is being expanded in a phased approach, with the aim of eventually offering it from age 60. From 1 September 2025, the following eligibility applies:
Immunocompetent Adults (Healthy Immune System)
| Age on 1 September 2025 | NHS Shingles Vaccine Eligibility |
| 65 | Currently eligible — being contacted from January 2026 |
| 66 | Currently eligible (catch-up) — being contacted from January 2026 |
| 67 | Currently eligible (catch-up) — being contacted from January 2026 |
| 68 | NOT currently eligible — becomes eligible 1 September 2027 |
| 69 | NOT currently eligible — becomes eligible 1 September 2026 |
| 70–79 | Currently eligible — can get vaccine up to 80th birthday |
| 80 or over | NOT eligible (cut-off at 80th birthday) |
| Under 65 | NOT eligible via routine programme — private vaccination available |
The phased rollout works on a rolling cohort basis: each September, a new age cohort becomes eligible. Those who have missed their invitation and remain under 80 (if aged 70+) or have not yet had the vaccine (aged 65-67) can still contact their local NHS immunisation team from January 2026 onwards.
Severely Immunosuppressed Adults (New from 1 September 2025)
From 1 September 2025, the NHS expanded eligibility to include all severely immunosuppressed adults aged 18 and over. This is a significant expansion — previously, immunosuppressed individuals had to be 50 or over. NHS England announced this change in August 2025, following advice from the Joint Committee on Vaccination and Immunisation (JCVI), which found that younger immunosuppressed people face a similar risk of shingles hospitalisation to older eligible cohorts.
Conditions that may qualify someone as severely immunosuppressed include:
- Leukaemia, lymphoma, or other haematological cancers
- People currently undergoing or who have recently completed chemotherapy
- Bone marrow or stem cell transplant recipients
- Solid organ transplant recipients on immunosuppressive therapy
- Severe primary immunodeficiency conditions
- People with HIV with a low CD4 count
Severely immunosuppressed individuals receive 2 doses of Shingrix, with the second dose given 8 weeks to 6 months after the first. If you believe you may qualify under this criterion, contact your GP surgery.
What Is the NHS Shingles Vaccine Green Book?
The ‘Green Book’ — formally titled ‘Immunisation Against Infectious Disease’ — is the UKHSA’s official reference guide for healthcare professionals responsible for delivering UK vaccination programmes. It covers every vaccine in the national schedule, providing detailed clinical guidance on eligibility criteria, dosing, contraindications, and special circumstances.
Chapter 28a of the Green Book specifically covers herpes zoster (shingles) vaccination. Searches for ‘green book shingles vaccine’ or ‘shingles vaccine green book’ typically come from GPs, practice nurses, pharmacists, and other healthcare professionals seeking the detailed clinical guidance. The full Green Book is publicly available via GOV.UK.
Shingles Vaccine Cost: Private Pricing 2026
If you are not eligible for the NHS shingles vaccine — most commonly because you are aged 50-64 with a healthy immune system — private vaccination is available with no GP referral required at most providers.
| Private Shingles Vaccine | Typical Cost (2026) |
| Single dose (Shingrix) | £200 – £280 per dose |
| Full 2-dose course | £400 – £500 total |
Pharmacy M confirmed pricing of £250 per dose as of April 2026, with the full two-dose course totalling £500. The two doses are given two to six months apart, so the cost is split across two appointments. Always confirm whether the quoted price includes a consultation fee — some clinics charge these separately, which can add to the headline dose price.
Private Shingrix is identical to the vaccine used on the NHS. The same GSK formulation, the same dosing schedule, and the same level of protection.
Why Are People Aged 50-64 in the ‘Age Gap’?
The NHS shingles programme is being rolled out in phases over a ten-year period. The long-term goal is to offer the vaccine from age 60. However, the programme started from the older age groups and is working downwards — so healthy adults aged 50-64 currently fall into what Pharmacy M calls the ‘age gap’: old enough to be at real risk, but not yet invited by the NHS.
The clinical case for private vaccination in this age group is clear: Shingrix is over 90% effective against shingles in adults aged 50+, and the consequences of shingles — particularly post-herpetic neuralgia — can be severe at any age. Private vaccination allows people in this age gap to take preventive action without waiting years for their NHS invitation.
Where to Get the Shingles Vaccine
Free on the NHS
- Your GP surgery: Contact your practice to confirm eligibility and book — GP practices deliver the shingles vaccine as part of their NHS immunisation responsibilities
- NHS immunisation team: If you have not received an invitation but believe you are eligible, contact your local NHS immunisation team. NHS Inform (Scotland) advises contacting the local immunisation team from January 2026 onwards for those who missed their initial invitation
- The vaccine can be given alongside other seasonal vaccines including flu and COVID-19 vaccinations
Privately
- Private pharmacies: Pharmacy M, Boots Travel and Vaccination Services, LloydsPharmacy clinical services, and many independent pharmacies offer Shingrix privately — no GP referral required
- Private GP practices: Many offer the shingles vaccine as a private health service
- Private travel clinics and vaccination clinics: Increasingly offering Shingrix alongside travel vaccinations
- Online booking available at most private providers — same-day and weekend appointments are commonly offered
Shingles Vaccine Side Effects
Shingrix has a more pronounced side effect profile than many other adult vaccines — this is because it contains an adjuvant called AS01B, which deliberately stimulates a stronger immune response to produce better long-term protection. The side effects are common but generally mild and short-lived.
- Very common (affecting more than 1 in 10): injection site pain, redness, and swelling; fatigue; muscle aches; headache; chills; fever; gastrointestinal symptoms (nausea, vomiting, diarrhoea)
- These effects typically appear within 24 hours of injection and usually resolve within 1-3 days
- Side effects may be more noticeable after the second dose than the first
- Serious side effects (such as severe allergic reaction) are very rare
The more noticeable side effects of Shingrix compared to Zostavax are widely documented — some people describe feeling similar to having a mild illness for 24-48 hours after vaccination. Paracetamol can help manage discomfort. It is worth scheduling the injection for a day when significant tiredness the next day will not cause major disruption.
Can You Get the Shingles Vaccine If You Have Already Had Shingles?
Yes. If you have previously had shingles, you can still benefit from vaccination — the vaccine boosts your immunity against future episodes. However, wait until the current episode of shingles has fully resolved before booking a vaccination appointment. Speak to your GP or pharmacist about the appropriate timing after a recent shingles episode.
Frequently Asked Questions
How much does the shingles vaccine cost privately in the UK?
Private Shingrix costs approximately £200-£280 per dose, with the full two-dose course costing £400-£500. Pharmacy M charges £250 per dose (£500 for the complete course) as of April 2026. Always confirm whether consultation fees are included in the quoted price.
Who gets the shingles vaccine free on the NHS in 2026?
From 1 September 2025: immunocompetent adults aged 65-67 (current cohort being rolled out) and adults aged 70-79 (up to their 80th birthday). Additionally, all severely immunosuppressed adults aged 18 and over (expanded from September 2025). Adults aged 50-64 with a healthy immune system are not currently eligible and must access the vaccine privately.
What is Shingrix?
Shingrix is the current NHS shingles vaccine made by GSK. It is a non-live, adjuvanted recombinant subunit vaccine given as two doses, 6-12 months apart (or 8 weeks to 6 months apart for immunosuppressed patients). It replaced the previous live single-dose Zostavax vaccine and is over 90% effective at preventing shingles in adults aged 50+.
What is the Green Book for shingles vaccine?
The Green Book (‘Immunisation Against Infectious Disease’) is the UKHSA’s official professional reference for UK vaccination programmes. Chapter 28a covers herpes zoster (shingles) vaccination. It is the authoritative source used by GPs, nurses, and pharmacists to guide clinical decisions about the shingles vaccine. It is publicly available on GOV.UK.
Can I get the shingles vaccine if I am 50-64?
Not free on the NHS (unless you are severely immunosuppressed — now eligible from age 18). However, private vaccination is available from many pharmacies and private clinics without a GP referral. The NHS programme is being expanded downwards in phases and will eventually reach the 60-64 age group.
Final Thoughts
The NHS shingles vaccination programme has improved significantly with the transition to Shingrix — a more effective, non-live vaccine that can be given to immunocompromised patients and provides over 90% protection. The September 2025 expansion to all severely immunosuppressed adults aged 18+ is particularly important. For the many healthy adults in their 50s and early 60s who are not yet eligible on the NHS, the private route offers the same high-quality Shingrix vaccine without a long wait. At approximately £250 per dose, the cost of private vaccination is not trivial — but for a condition that can cause weeks of severe pain and months of debilitating nerve damage, many people in the age gap consider it well worth investing in.
This article is for educational purposes only. Consult your GP or pharmacist for advice specific to your health situation.